Physician profile
Nancy A Nora
NPI 1205846367
$1,173.12
in general payments reported to CMS, 2019-2025
10 companies · $27.65 in 2025
The $27.65 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2021: $233 · 2022: $365 · 2023: $159 · 2024: $265 · 2025: $27.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $556.63 | 2021-2024 | Farxiga, Lokelma |
| Bayer Healthcare Pharmaceuticals INC. | $157.72 | 2022 | |
| Glaxosmithkline, LLC. | $123.82 | 2023 | Benlysta |
| Otsuka America Pharmaceutical, INC. | $123.28 | 2019 | |
| Aurinia Pharma U.S., INC. | $96.41 | 2022 | |
| Travere Therapeutics, INC. | $44.30 | 2023-2025 | |
| Fresenius USA Marketing, INC. | $31.37 | 2024 | Crit-Line |
| Calliditas Therapeutics US INC. | $15.09 | 2025 | Tarpeyo |
| Amgen INC. | $12.36 | 2022 | |
| Vifor Pharma, INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Nora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.